Correlation Between ADHI KARYA and CanSino Biologics

Can any of the company-specific risk be diversified away by investing in both ADHI KARYA and CanSino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ADHI KARYA and CanSino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ADHI KARYA and CanSino Biologics, you can compare the effects of market volatilities on ADHI KARYA and CanSino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ADHI KARYA with a short position of CanSino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ADHI KARYA and CanSino Biologics.

Diversification Opportunities for ADHI KARYA and CanSino Biologics

-0.65

Correlation Coefficient

ADHI KARYA  CanSino Biologics

Excellent diversification

The 3 months correlation between ADHI and CanSino is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding ADHI KARYA and CanSino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CanSino Biologics and ADHI KARYA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ADHI KARYA are associated (or correlated) with CanSino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CanSino Biologics has no effect on the direction of ADHI KARYA i.e., ADHI KARYA and CanSino Biologics go up and down completely randomly.

Pair Corralation between ADHI KARYA and CanSino Biologics

Assuming the 90 days trading horizon ADHI KARYA is expected to under-perform the CanSino Biologics. In addition to that, ADHI KARYA is 1.13 times more volatile than CanSino Biologics. It trades about -0.34 of its total potential returns per unit of risk. CanSino Biologics is currently generating about 0.18 per unit of volatility. If you would invest  330.00  in CanSino Biologics on September 27, 2024 and sell it today you would earn a total of  36.00  from holding CanSino Biologics or generate 10.91% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

ADHI KARYA  vs.  CanSino Biologics

ADHI KARYA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ADHI KARYA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

CanSino Biologics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in CanSino Biologics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, CanSino Biologics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with ADHI KARYA and CanSino Biologics

The main advantage of trading using opposite ADHI KARYA and CanSino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ADHI KARYA position performs unexpectedly, CanSino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CanSino Biologics will offset losses from the drop in CanSino Biologics' long position.

The idea behind ADHI KARYA and CanSino Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.